Rising Demand for Treatments in Retinal Vein Occlusion Market Driven by Diabetes and Atherosclerosis

The global Retinal Vein Occlusion (RVO) market size was USD 2.46 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.7% during the forecast period. The global Retinal Vein Occlusion Market is experiencing significant growth due to the increasing prevalence of diabetes and atherosclerosis, alongside heightened research and development activities aimed at developing new treatment options. The market is further bolstered by a strong pipeline of drugs and recent approvals designed to treat this eye condition.

Retinal Vein Occlusion occurs when small veins that carry blood away from the retina become blocked, leading to potential vision loss. This condition can manifest as sudden blurring or loss of vision in one eye and is primarily caused by hardening of the veins (atherosclerosis) and blood clot formation. Treatments vary based on the severity and type of occlusion, which is categorized into two main types: Central Retinal Vein Occlusion (CRVO) and Branch Retinal Vein Occlusion (BRVO).

Current treatment methods include anti-vascular endothelial growth factor (anti-VEGF) injections and focal laser procedures. According to the World Health Organization (WHO), around 1.28 billion adults aged between 30 and 79 globally suffer from hypertension, a key risk factor for retinal vein occlusions.

To learn about additional key drivers, trends, and challenges - Read our Sample Report right now @ https://www.emergenresearch.com/request-sample/2839

Key Drivers of Market Growth

Technological advancements, particularly in Artificial Intelligence (AI), the Internet of Things (IoT), and Machine Learning (ML), are significantly enhancing the Retinal Vein Occlusion market. Innovations in automation and robotics are improving productivity and efficiency in treatment procedures, leading to faster and more accurate results. Companies are increasingly launching advanced products utilizing these technologies, aiming to provide better patient experiences.

Challenges in the Market

Despite its growth potential, the Retinal Vein Occlusion market faces challenges such as high equipment costs and stringent government regulations, which may hinder access to treatments in economically disadvantaged regions. The high costs associated with advanced technology can limit accessibility, particularly in countries with limited healthcare budgets.

Market Segmentation Insights

Disease Type:

Central Retinal Vein Occlusion (CRVO): This segment is currently the largest in the market, attributed to the increasing development of specific drugs targeting CRVO. For example, a new anti-VEGF monoclonal antibody, 601A, is in clinical trials aimed at treating CRVO.

Branch Retinal Vein Occlusion (BRVO): This segment is expected to see steady growth due to ongoing research and treatment developments. Recent advancements, such as Vabysmo Intravitreal Injection by Chugai Pharmaceutical, highlight the focus on BRVO treatment.

Treatment Method:

Anti-VEGF Treatments: This category is anticipated to capture a significant market share, as these treatments have proven effective in preventing vision loss. Key players are developing novel anti-VEGF therapies, further driving market revenue.

Corticosteroid Drugs: This segment is projected to grow moderately due to the efficacy of corticosteroids in managing retinal vein occlusion by stabilizing the blood-retina barrier and reducing edema.

End-Use:

Retail Pharmacy: This segment is poised to dominate the market as patients increasingly access treatments and medications through local pharmacies. Retail pharmacies play a crucial role in providing patient education and support, enhancing accessibility and convenience for patients.

Get Brief Information @ https://www.emergenresearch.com/industry-report/retinal-vein-occlusion-market

Retinal Vein Occlusion Top Companies and Competitive Landscape

The global Retinal Vein Occlusion market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective Retinal Vein Occlusion solutions.

Some major players included in the global Retinal Vein Occlusion market report are:

Taiwan Liposome Company, Ltd.

Outlook Therapeutics, Inc.

Chugai Pharmaceutical Co., Ltd.

Hoffmann-La Roche Ltd.

CalciMedica Inc.

Kodiak Sciences Inc.

Pfizer Inc.

AbbVie Inc.

Lumenis

Aerie Pharmaceuticals Inc.

Retinal Vein Occlusion Latest Industry Updates

In January 2022, Mentor Worldwide LLC (a subsidiary of the Johnson & Johnson Medical Devices Companies) announced that Food and Drug Administration (FDA) had approved the MENTOR MemoryGel BOOST breast implant for breast augmentation and breast reconstruction. This product has helped the company to enhance its product portfolio of aesthetics in the U.S. market.

In December 2021, Allergan Aesthetics, part of AbbVie, acquired a medical technology company, Soliton, Inc. This acquisition helped the company to strengthen its portfolio of non-invasive body contouring treatments.

Retinal Vein Occlusion Market Segmentation Analysis

For the purpose of this report, Emergen Research has segmented the global Retinal Vein Occlusion market on the basis of disease type, treatment, condition, end-use, and region:

Disease Type Outlook (Revenue, USD Billion; 2019-2032)

Central Retinal Vein Occlusion (CRVO)

Branch Retinal Vein Occlusion (BRVO)

Treatment Outlook (Revenue, USD Billion; 2019-2032)

Anti-vascular Endothelial Growth Factor (Anti-VEGF)

Corticosteroid drugs

Laser therapy

Others

Condition Outlook (Revenue, USD Billion; 2019-2032)

Ischemic

Non ischemic

End-Use Outlook (Revenue, USD Billion; 2019-2032)

Hospital & clinics

Retail pharmacy

Others

Regional Outlook (Revenue, USD Billion; 2019-2032)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Benelux

Russia

Rest of Europe

Asia Pacific

China

Japan

South Korea

India

ASEAN Countries

Oceania

Rest of APAC

Latin America

Brazil

Mexico

Rest of LATAM

Middle East & Africa

GCC Countries

Israel

Turkey

South Africa

Rest of Middle East & Africa

Buy Now: @ https://www.emergenresearch.com/select-license/2839

Comprehensive Market Report: Understanding Trends and Opportunities

Retinal Vein Occlusion (RVO) Market Size @ https://www.emergenresearch.com/industry-report/retinal-vein-occlusion-market/market-size

Retinal Vein Occlusion (RVO) Market Share @ https://www.emergenresearch.com/industry-report/retinal-vein-occlusion-market/market-share

Retinal Vein Occlusion (RVO) Market Trends @ https://www.emergenresearch.com/industry-report/retinal-vein-occlusion-market/market-trends

Retinal Vein Occlusion (RVO) Regional Market Demand @ https://www.emergenresearch.com/industry-report/retinal-vein-occlusion-market/regional-market-demand

Retinal Vein Occlusion (RVO) Market Analysis @ https://www.emergenresearch.com/industry-report/retinal-vein-occlusion-market/market-analysis

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.